Liberate Medical

Focus: Liberate Medical develops respiratory electrical muscle stimulators, a niche medical device platform targeting artificial respiration and chronic respiratory diseases. The company operates as a pre-revenue biotech focused on functional electrical stimulation (FES) technology.

Respiratory

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Liberate Medical

AI assessmentNot Hiring

No open roles listed right now. Follow Liberate Medical to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

4 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

VentFree prototype

Mechanical Ventilation Complication

N/A

Clinical Trials (1)

NCT03453944NMES to Prevent Respiratory Muscle Atrophy in Mechanically Ventilated Patients

N/A

Help build intelligence for Liberate Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage respiratory device innovation with 4 active clinical programs addressing unmet needs in ventilation and COPD management
Opportunity to build company infrastructure and establish cross-functional processes in a pre-commercialization stage
Emerging therapeutic area (neuromuscular electrical stimulation) with limited competitive saturation in pharma/biotech

Watch Out For

Currently zero active job openings and no disclosed funding, staffing levels, or revenue generation signal significant early-stage risk
All pipeline programs remain in early/exploratory phase (no Phase 1+ classification) with minimal publication record (0 listed), suggesting limited clinical validation or peer-reviewed validation
Location in Crestwood, KY may limit access to major pharma hubs and talent networks typical of San Francisco, Boston, or New Jersey biotech ecosystems

Generated by Claude from Liberate Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Abdominal Stimulation - low / early

Pulmonary Disease, Chronic Obstructive

N/A

Clinical Trials (1)

NCT02035228Abdominal Functional Electrical Stimulation to Reduce Hyperinflation in Chronic Obstructive Pulmonary Disease Patients

N/A

Breath synchronized abdominal NMES

Electric Stimulation

N/A

Clinical Trials (1)

NCT03019107Breath Synchronized Abdominal Muscle Stimulation to Facilitate Ventilator Weaning: a Pilot Study

N/A

Breath synchronized abdominal FES

Respiration, Artificial

N/A

Clinical Trials (1)

NCT05759013Pivotal Evaluation of Abdominal Neuromuscular Electrical Stimulation (VentFree) for Weaning From Mechanical Ventilation

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 4 clinical trials

Top TAs: Respiratory

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Respiratory

1 pipeline

Marketed

Pipeline